Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4at2 | ASD | Possible succinate dehydrogenase |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4at2 | ASD | Possible succinate dehydrogenase | / | 1.000 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.502 | |
2fpc | SCG | Strictosidine synthase | 4.3.3.2 | 0.497 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.496 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.487 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.487 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.485 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.481 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.480 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.480 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2z7g | EH9 | Adenosine deaminase | 3.5.4.4 | 0.478 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
1fmj | RTL | Retinol dehydratase | / | 0.476 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.476 | |
3ns2 | PYV | Abscisic acid receptor PYL2 | / | 0.476 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.474 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.474 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.473 | |
1ndz | FR5 | Adenosine deaminase | 3.5.4.4 | 0.472 | |
1ie8 | KH1 | Vitamin D3 receptor | / | 0.469 | |
1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.469 | |
1j3j | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.468 | |
1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
2hc4 | VDX | Vitamin D3 receptor A | / | 0.466 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.466 | |
1vj3 | TAB | Dihydrofolate reductase | 1.5.1.3 | 0.465 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.465 | |
2blc | CP7 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.464 | |
2v58 | LZJ | Biotin carboxylase | 6.3.4.14 | 0.464 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.464 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.464 | |
5dn1 | AMZ | Phosphoribosyl isomerase A | 5.3.1.16 | 0.464 | |
4qa2 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.463 | |
2ham | C33 | Vitamin D3 receptor | / | 0.462 | |
3cse | N22 | Uncharacterized protein | / | 0.462 | |
3iel | U5P | Ribonuclease TTHA0252 | 3.1 | 0.462 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3um5 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.462 | |
4h95 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
4jub | TPP | Benzoylformate decarboxylase | 4.1.1.7 | 0.462 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
1al8 | DHP | Peroxisomal (S)-2-hydroxy-acid oxidase | 1.1.3.15 | 0.461 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.461 | |
2bl9 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.461 | |
3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.461 | |
3qfx | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.461 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.461 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
2giu | FBR | Estrogen receptor beta | / | 0.460 | |
2vag | V25 | Dual specificity protein kinase CLK1 | 2.7.12.1 | 0.460 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.460 | |
4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.460 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.460 | |
1h1p | CMG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
1rx6 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
2bla | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.459 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.458 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
3qly | 55V | Uncharacterized protein | / | 0.458 | |
1tvr | TB9 | Gag-Pol polyprotein | 2.7.7.49 | 0.457 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.457 | |
3niz | ADP | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.457 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
1j3i | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.456 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.456 | |
3b5i | SAH | Indole-3-acetate O-methyltransferase 1 | / | 0.456 | |
3pqb | VGP | Putative oxidoreductase | / | 0.456 | |
3qn1 | A8S | Abscisic acid receptor PYR1 | / | 0.456 | |
4ds8 | A8S | Abscisic acid receptor PYL3 | / | 0.456 | |
1f4g | TP4 | Thymidylate synthase | / | 0.455 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4ite | TEY | Vitamin D3 receptor | / | 0.455 | |
1s0z | EB1 | Vitamin D3 receptor | / | 0.454 | |
1s3y | TQT | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
1tdc | UMP | Thymidylate synthase | / | 0.454 | |
2g1p | SAH | DNA adenine methylase | 2.1.1.72 | 0.454 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.454 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.454 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.454 | |
4fhh | 0U3 | Vitamin D3 receptor A | / | 0.454 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.454 | |
1kl2 | FON | Serine hydroxymethyltransferase | / | 0.453 | |
1nhz | 486 | Glucocorticoid receptor | / | 0.453 | |
2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.453 | |
2oax | SNL | Mineralocorticoid receptor | / | 0.453 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.453 | |
4o71 | CPB | Bromodomain-containing protein 4 | / | 0.453 | |
1daj | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.452 | |
3lan | KBT | Gag-Pol polyprotein | 2.7.7.49 | 0.452 | |
3qlw | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
3srs | M23 | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.452 | |
4h98 | 14Q | Uncharacterized protein | / | 0.452 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
1rf7 | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.451 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.451 | |
3qlz | QLZ | Uncharacterized protein | / | 0.451 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.451 | |
4rr7 | A3S | Probable threonine--tRNA ligase 2 | 6.1.1.3 | 0.451 | |
1klm | SPP | Gag-Pol polyprotein | 2.7.7.49 | 0.450 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.450 | |
2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
3dhc | CYK | N-acyl homoserine lactonase AiiA | 3.1.1.81 | 0.450 | |
3vrv | YSD | Vitamin D3 receptor | / | 0.450 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.450 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.449 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.449 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2fzj | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.449 | |
3gwf | NAP | Cyclohexanone monooxygenase | / | 0.449 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.449 | |
3sh2 | 5DR | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4i7f | NVE | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
5d7q | 4I5 | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.449 | |
1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2j8z | NAP | Quinone oxidoreductase PIG3 | 1 | 0.448 | |
3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.448 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.448 | |
3pd3 | A3T | Threonine--tRNA ligase | 6.1.1.3 | 0.448 | |
3sru | Q26 | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.448 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4lsj | LSJ | Glucocorticoid receptor | / | 0.448 | |
4pkl | 1GH | Uncharacterized protein | / | 0.448 | |
4rup | H97 | Vitamin D3 receptor A | / | 0.448 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
1tw2 | ERT | Carminomycin 4-O-methyltransferase DnrK | 2.1.1.292 | 0.447 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.447 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.447 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.447 | |
3h3t | 16H | Collagen type IV alpha-3-binding protein | / | 0.447 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
3vtb | TKA | Vitamin D3 receptor | / | 0.447 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
4fi1 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
4g21 | 0VP | Vitamin D3 receptor A | / | 0.447 | |
4jvm | XDI | Estrogen sulfotransferase | 2.8.2.4 | 0.447 | |
1m7a | MQU | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1rx5 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1v79 | FR7 | Adenosine deaminase | 3.5.4.4 | 0.446 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.446 | |
2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 0.446 | |
2xvw | 9NR | Serum albumin | / | 0.446 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.446 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.446 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.446 | |
1ddu | CB3 | Thymidylate synthase | / | 0.445 | |
1e7w | MTX | Pteridine reductase 1 | 1.5.1.33 | 0.445 | |
1tlc | F89 | Thymidylate synthase | / | 0.445 | |
1x8l | OXR | Retinol dehydratase | / | 0.445 | |
3h18 | PMS | Esterase/lipase | / | 0.445 | |
3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.445 | |
3qgt | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.445 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.445 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.445 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.445 | |
4mry | CEI | Obelin | / | 0.445 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.445 | |
5ccc | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1fko | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
1lhv | NOG | Sex hormone-binding globulin | / | 0.444 | |
1o5r | FR9 | Adenosine deaminase | 3.5.4.4 | 0.444 | |
1s19 | MC9 | Vitamin D3 receptor | / | 0.444 | |
2azy | CHD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.444 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.444 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3u8h | BHP | Phospholipase A2, membrane associated | / | 0.444 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.444 | |
4f70 | 0ST | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.444 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
1cqp | 803 | Integrin alpha-L | / | 0.443 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3sai | 9DR | Dihydrofolate reductase | / | 0.443 | |
3sgv | 2BJ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
3tvq | DQH | Multifunctional cyclase-dehydratase-3-O-methyl transferase TcmN | 2.1.1 | 0.443 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.443 | |
4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1lud | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2w3w | VG9 | Dihydrofolate reductase | / | 0.442 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4dpd | DHF | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.442 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.441 | |
1kt3 | RTL | Retinol-binding protein 4 | / | 0.441 | |
1mrq | STR | Aldo-keto reductase family 1 member C1 | / | 0.441 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.441 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.441 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.441 | |
3mx5 | UTP | Nucleoprotein | / | 0.441 | |
3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.441 | |
3oa2 | NAD | UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate oxidase | / | 0.441 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
4aoi | 4K0 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.441 | |
4g20 | 484 | Vitamin D3 receptor A | / | 0.441 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.441 | |
4iyg | 1HU | Strictosidine synthase | 4.3.3.2 | 0.441 | |
4jzr | 4JR | Egl nine homolog 1 | / | 0.441 | |
3qak | UKA | Adenosine receptor A2a | / | 0.441 | |
1kqw | RTL | Cellular retinol-binding protein type II | / | 0.440 | |
1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2xwe | AMF | Glucosylceramidase | 3.2.1.45 | 0.440 | |
3ely | SAH | Methyltransferase | / | 0.440 | |
3ey4 | 352 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
3jzi | JZL | Biotin carboxylase | 6.3.4.14 | 0.440 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3ujl | A8S | Abscisic acid receptor PYL2 | / | 0.440 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.440 | |
4bqp | VMY | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
4dp3 | MMV | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.440 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.440 | |
4ixe | IXE | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
4l8u | 9AZ | Serum albumin | / | 0.440 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.440 | |
4tx9 | AMZ | Phosphoribosyl isomerase A | / | 0.440 |